Cambridge Investment Research Advisors
PETS icon

Cambridge Investment Research Advisors’s PetMed Express PETS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,150
Closed -$216K – 3156
2021
Q1 		$216K Buy
+6,150
New +$214K ﹤0.01% 2550
2020
Q1 		– Sell
-8,759
Closed -$206K – 2423
2019
Q4 		$206K Sell
8,759
-2,965
-25% -$66.4K ﹤0.01% 2191
2019
Q3 		$211K Buy
+11,724
New +$194K ﹤0.01% 2074

Other funds holding PETS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cambridge Investment Research Advisors's PETS Position: Q2 2021 in Review

Cambridge Investment Research Advisors sold out of PetMed Express (PETS) in Q2 2021, closing a stake of 6,150 shares — an estimated $216K sold.

Cambridge Investment Research Advisors first reported a position in PETS in Q3 2019 and held it in 3 quarters. The position peaked at $216K in Q1 2021. 198 funds tracked by Wall St. Rank hold PETS as of Q2 2021.

  • Cambridge Investment Research Advisors reported no remaining PetMed Express position as of Q2 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 6,150 PetMed Express shares in Q2 2021, an estimated $216K.
  • Cambridge Investment Research Advisors first reported a position in PetMed Express in Q3 2019 and held it in 3 quarters.
  • Cambridge Investment Research Advisors's PetMed Express position peaked at $216K in Q1 2021.
  • 198 funds tracked by Wall St. Rank held PetMed Express as of Q2 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.